Bill Gates says Trump’s coronavirus treatment won’t work for everyone, shouldn’t be called ‘cure’

Microsoft co-founder and billionaire philanthropist Bill Gates said Sunday that the Regeneron antibody cocktail administered to President Trump to treat a case of COVID-19 shouldn’t be referred to as a “cure.”

“The word ‘cure’ is inappropriate because it doesn’t work for everyone,” Gates told NBC’s “Meet the Press.” “But yes, of all the therapeutics, this is the most promising.”

Although an effective vaccine is an ultimate goal for putting an end to the pandemic, Gates noted that monoclonal antibodies allow for treatment that doesn’t require admission to a high percentage of the population.

“With the monoclonal antibodies, it’s only once somebody tests positive, show symptoms and they’re old enough they’re at risk,” Gates said. “That’s the target for this therapeutic.”

He added that if the monoclonal antibody treatments can be approved for

Read More

Bill Gates on Trump virus treatment: The word ‘cure’ is inappropriate because it won’t work for everyone

Microsoft founder and philanthropist Bill Gates said Sunday that the monoclonal antibodies treatment President TrumpDonald John TrumpNorth Korea unveils large intercontinental ballistic missile at military parade Trump no longer considered a risk to transmit COVID-19, doctor says New ad from Trump campaign features Fauci MORE received for his coronavirus infection is not a “cure,” but is the most promising option thus far.

“The word ‘cure’ is inappropriate because it won’t work for everyone,” Gates said Sunday on NBC’s “Meet the Press.” “But of all the therapeutics, this is the most promising.”

Gates added that the Bill & Melinda Gates Foundation has “been working with companies doing antibodies, we reserved factory capacity back in the spring, and now we’re partnered with Eli Lilly, who with Regeneron, has been the fastest to get these antibodies ready.”

Read More

Trump hails his COVID ‘cure’ as leading medical journal calls him ‘dangerously incompetent’ on pandemic






© Yahoo News



President Trump continued to hail an experimental monoclonal antibody treatment as a “cure” for COVID-19, telling conservative radio host Rush Limbaugh in a Friday interview that it sped his recovery from the disease and was “better than a vaccine.”

“I was not in great shape, but we have a medicine that healed me, that fixed me,” Trump said of the antibody “cocktail” manufactured by Regeneron Pharmaceuticals. “It’s a great medicine. I recovered immediately.”

Since being released on Monday from Walter Reed National Military Medical Center, where he was treated for three days after being admitted with a high fever, chills and breathing problems, Trump has often pointed to the antibody therapy he undertook at the hospital as a “cure” for COVID-19. There is no known cure for the disease caused by exposure to the coronavirus, and the FDA has not, so far, approved the drug’s use

Read More

Trump’s Regeneron Antibody Treatment Is Not a ‘Cure’

First, there simply are not yet enough doses in the world. Regeneron currently has enough doses for 50,000 patients. Eli Lilly, which makes a different COVID-19 monoclonal-antibody therapy that is also in clinical trials, says it will have 100,000 doses in October. To put that in context, the United States has 50,000 new cases of COVID-19 every day.

The manufacturing of monoclonal antibodies can’t just scale up on a dime to treat everyone, says Howard Levine, who leads a group of pharmaceutical manufacturing consultants at BioProcess Technology Group. The antibodies are made inside large stainless-steel tanks using genetically engineered ovary cells from hamsters. Like all living things, they can grow only so fast. The tanks are also sophisticated pieces of equipment that can take months to install, Levine says. Regeneron and Eli Lilly have already been increasing manufacturing capacity, and they expect to have

Read More

COVID drug Trump touted as a “cure” was developed using cells derived from aborted fetal tissue

The antibody cocktail that President Trump received for his COVID-19 infection and touted on Wednesday evening as a “cure” for the deadly virus was developed using cells derived from aborted fetal tissue, a practice the White House and anti-abortion rights groups oppose.

Last week, Mr. Trump received Regeneron Pharmaceuticals’ cocktail of monoclonal antibodies, an experimental therapeutic for coronavirus that is still undergoing testing and is not FDA approved. In a nearly five-minute video posted to Twitter on Wednesday, the president lauded its effects, calling it “the key.”

“I think this was a blessing from God that I caught [the virus], I think it was a blessing in disguise,” Mr. Trump said in the video. “I caught it, I heard about this drug, I said, ‘Let me take it’ … and it was incredible the way it worked.”

But the way in which the antibody cocktail was developed is at

Read More

Trump politicizes promising coronavirus antibody treatments, erroneously calling them a ‘cure’

Trump also claimed in the videos he had granted the drugs an emergency use authorization (EUA), a designation that would make the medicines more broadly available. But the companies said they have submitted the requests to the Food and Drug Administration — a process that the agency has repeatedly tried to assure the public is based on science and free of political interference.

“We’re going to make them available immediately, we have an emergency use authorization that I want to get signed immediately,” Trump said in the video posted Thursday afternoon.

Experts said that by inserting himself and his own recovery story into an area of ongoing medical research, Trump risks disappointing and confusing the American public with a hopeful anecdote that may not reflect how the drug works for others or how broadly it will become available when it is approved, which he also promised would be free.

“The

Read More

Trump claims his Covid treatment means a cure is imminent

“Hi, perhaps you recognize me — it’s your favorite president,” Trump said.

“I wasn’t feeling so hot and within a short period of time they gave me Regeneron,” he said, referring to drug company that makes the experimental antibody cocktail he received. “It was unbelievable. I felt good immediately. I felt as good three days ago as I do now.”

Trump later said of the drug, “I call that a cure,” and suggested that his infection was “a blessing from god” that revealed the drug’s promise. “I think if I didn’t catch [the virus] we’d be looking at that like a bunch of other drugs.

The president for months has also been promising that a coronavirus vaccine is imminent, often pledging to make it available by Election Day. Late-stage clinical trials are underway, but no vaccine maker has yet sought emergency authorization or approval from the Food and Drug

Read More

6 Health & Wellness Facilities Cure the Blues

From Los Angeles to London and stops in between, these wellness-minded facilities are just what the doctor ordered.


Photography by Connie Zhou.

Firm: ZGF Architects

Project: Lundquist Institute for Biomedical Innovation Medical Research Laboratory 1, L.A.

Standout: More than just a lab, the structure’s glazed facade with angled projections creates a sense of arrival and ushers in abundant natural light to airy, industrial-chic spaces designed specifically for fundraising, presentations, and entertaining.


Photography by Kim Rogers.

Firm: CO Architects

Project: Outpatient Surgery at Cedars-Sinai Advanced Health Sciences Pavilion, L.A.

Standout: In addition to the technical and functional expertise required to plan dozens of ORs and pre-op and post-anesthesia care units, the 45,000 square feet also deliver a sense of calm through cloudlike ceiling forms of acoustical plaster rimmed with fiber-optics.


Photography by Loop Audiovisual.

Firm: Pedra Silva Arquitectos

Project: Maida

Read More

Mind Cure Receives Health Canada Authorization to Sell its Moonbeam Mushroom Products in Canada

Health Canada Issues Natural Product Number Licenses to Mind Cure

VANCOUVER, BC, Sept. 23, 2020 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (“Mind Cure” or the “Corporation”) is pleased to announce that on September 17, 2020 it received the final authorizations from Health Canada to sell its Moonbeam functional mushroom products in Canada. Health Canada has issued Natural Product Numbers (NPN) to these products, which means that they were assessed by Health Canada and found to be “safe, effective and of high quality under their recommended conditions of use.” (source: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/licensed-natural-health-products-database.html).

Mind Cure is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health. Mind Cure was formed as a response to a world suffering from a mental health crisis and in urgent need of effective treatments. Mind Cure’s goal is

Read More

‘Sounds Of Silence’ For Cancer Cure Deafening

The Major News Media missed reporting a breakthrough treatment for the prevention of cancer. Why? Is it because this breakthrough isn’t a drug but a simple inexpensive multivitamin with folic acid that can prevent cancers up to 50%? If it were a pharmaceutical that achieved such astounding results it would be in all the news reports on television and newspapers. Is it because there is a bias against vitamins and nutrition which are non-drug treatments or because there is no benefit for Big Pharma?

The headline in the New York Times, LA Times, etc and the sound-bite on the CBS, ABC, NBC, FOX evening news should have read:

New Major Cancer Protective Treatment – A New Breakthrough ‘Drug’ That Prevents Cancers in Children –

Unfortunately it didn’t. I Googled this study from the February 21, 2007, medical journal Clinical Pharmacology and Therapeutics and nada! The major news outlets in Canada … Read More